CC
Commodore Capital Portfolio holdings
AUM
$2.05B
1-Year Est. Return
118.14%
1 Year Est. Return
+118.14%
AUM
$1.42B
AUM Growth
+$59.6M
(+4.4%)
Holding
38
Top Buys
| 1 | +$59.4M | |
| 2 | +$57.2M | |
| 3 | +$46.2M | |
| 4 |
Kymera Therapeutics
KYMR
|
+$32.7M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$21.9M |
Top Sells
| 1 | +$62.3M | |
| 2 | +$49.9M | |
| 3 | +$47.3M | |
| 4 |
Soleno Therapeutics
SLNO
|
+$45.2M |
| 5 |
Vera Therapeutics
VERA
|
+$41.5M |
Sector Composition
| 1 | Healthcare | 99.44% |
| 2 | Financials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merus
MRUS
$7.28B
| $185M | 13.09% |
3,525,000
-947,840
|
|
||
2
Nuvalent
NUVL
$7.02B
| $105M | 7.41% |
1,375,000
-480,000
|
|
||
|
3
Xenon Pharmaceuticals
XENE
$3.15B
| $94.7M | 6.68% |
3,025,000
+700,000
|
|
||
4
Enliven Therapeutics
ELVN
$1.31B
| $94.1M | 6.64% |
4,692,809
+17,809
|
|
||
5
Agios Pharmaceuticals
AGIO
$2.55B
| $77.3M | 5.46% |
2,325,000
+140,000
|
|
||
6
Celldex Therapeutics
CLDX
$1.7B
| $70.2M | 4.96% |
3,450,000
+250,000
|
|
||
7
Alkermes
ALKS
$4.8B
| $70.1M | 4.95% |
2,450,000
+500,000
|
|
||
8
Viridian Therapeutics
VRDN
$2.74B
| $68.2M | 4.81% |
4,875,000
+1,275,000
|
|
||
9
Protagonist Therapeutics
PTGX
$5.29B
| $59.4M | 4.19% |
+1,075,000
|
|
||
10
Cidara Therapeutics
CDTX
$6.84B
| $57.2M | 4.04% |
+1,175,000
|
|
||
11
Scholar Rock
SRRK
$3.6B
| $51.4M | 3.63% |
1,450,000
-295,000
|
|
||
|
12
Soleno Therapeutics
SLNO
$2.65B
| $51.1M | 3.61% |
610,000
-540,000
|
|
||
13
Relay Therapeutics
RLAY
$1.09B
| $46.2M | 3.26% |
+13,350,000
|
|
||
14
Nurix Therapeutics
NRIX
$1.3B
| $45M | 3.17% |
3,948,653
-30,254
|
|
||
|
CNTA
15
Centessa Pharmaceuticals
CNTA
$3.71B
| $43.3M | 3.06% |
3,298,289
+930,711
|
|
||
16
Pharvaris
PHVS
$1.53B
| $33.6M | 2.37% |
1,911,433
|
|
||
|
17
Kymera Therapeutics
KYMR
$4.67B
| $32.7M | 2.31% |
+750,000
|
|
||
18
MindMed
MNMD
$1.1B
| $32.5M | 2.29% |
5,000,000
+475,000
|
|
||
19
Spyre Therapeutics
SYRE
$1.82B
| $29.8M | 2.1% |
1,988,084
|
|
||
20
Tyra Biosciences
TYRA
$840M
| $29.7M | 2.09% |
3,100,000
+2,150,000
|
|
||
|
21
Vera Therapeutics
VERA
$1.81B
| $18.8M | 1.33% |
800,000
-1,761,782
|
|
||
22
CytomX Therapeutics
CTMX
$657M
| $17.5M | 1.23% |
+7,692,300
|
|
||
23
Cogent Biosciences
COGT
$5.15B
| $16.6M | 1.17% |
2,311,164
-6,581,652
|
|
||
|
ORKA
24
Oruka Therapeutics
ORKA
$1.31B
| $15.9M | 1.12% |
1,419,714
|
|
||
|
DRUG
25
Bright Minds Biosciences
DRUG
$410M
| $13.1M | 0.92% |
500,000
|
|